Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01100853Phase 3Completed
A Phase 3 trial of naltrexone in amphetamine dependence, sponsored by University of Pennsylvania. Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01100853.